The National Genomic Test Directory specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test.
Non-urgent advice: The National Genomic Test Directory
Access the current complete National Genomic Test Directory via NHS England.
Including:
- National Genomic Test Directory for Rare and Inherited Disease
- Rare and Inherited Disease Eligibility Criteria
- National Genomic Test Directory for Cancer
The National Genomic Test Directories are regularly updated, so please always consult the latest directory from NHS England when ordering tests.
Updating the National Genomic Test Directory
Anyone can apply to update the Test Directory, whether to consider new test targets, clinical indications and/or changes to the existing tests. The evaluation of applications to update the Test Directory will include an assessment of the clinical utility, unmet need and benefit to patients evidenced by the data. The process involves clinical and scientific experts, and patient and public voice representatives, ensuring patients are involved in all decisions.
Updating Gene Panel Content
The main Genomics England PanelApp (opens in a new tab) knowledge base is used to collate gene-disease association evidence for the Genomic Medicine Service (GMS) and other projects. GMS gene panels can be identified by the Clinical Indication R code and the blue bar at the top of the panel webpage.
Approved reviewers can add evidence for a gene or suggest that additional genes should be added to a panel. Changes to the GMS panel content will be evaluated through the genomic test evaluation process and will only be added to the GMS panels following approval through the NHS England and NHS Improvement process.
You can register to be a PanelApp reviewer here (opens in a new tab).
If you have any questions regarding this information, please email england.testevaluation@nhs.net